Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Pidolic acid is a naturally occurring amino acid derivative and a cyclic derivative of glutamic acid. Also known as 5-oxoproline or L-pyroglutamic acid, it is found in various tissues throughout the human body—especially in the brain and skin—and plays roles in several metabolic pathways including the gamma-glutamyl cycle involved in glutathione metabolism[1][2][3][5]. Pidolic acid acts as an intermediate in amino acid metabolism and has been studied for its antioxidant and anti-inflammatory properties. It can form complexes with minerals (as "pidolates") to enhance their bioavailability[1][6]. While not approved as a pharmaceutical drug for any specific indication, it is used as an ingredient in dietary supplements marketed for cognitive enhancement and mineral supplementation (e.g., zinc or magnesium pidolate), as well as cosmetic products due to its humectant properties[2][4][5]. Mechanistically, it may support neurotransmitter regulation and act on the cholinergic system; however, more research is needed to establish clinical benefits[1][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Pidolic acid.